AACR Annual Meeting 2026
WuXi AppTec is pleased to participate in the AACR Annual Meeting 2026, taking place April 17–22, 2026, in San Diego, California. This premier global oncology conference brings together researchers, clinicians, industry leaders, and patient advocates to share the latest advances in cancer science and medicine.
We are proud to present multiple posters at this year's meeting, detailing the latest scientific insights and covering a range of cutting-edge topics, from immunotherapy combinations, drug resistance, and ADC development to protein degraders and CAR-T therapy. We look forward to connecting in San Diego and discussing how WuXi AppTec can support your oncology research and development initiatives.
Stop by Booth 4049 to get your questions answered by one of our experts!
Session Category: Experimental and Molecular Therapeutics
• EpCAM-CD3 Bispecific Antibody-Encoding mRNA Delivered by Lung-Targeted Lipid Nanoparticles Suppresses Orthotopic Lung Tumor Growth
Poster Section 12 | Board 3 | #260
April 19 | 14:00–17:00
• Unveiling Mechanisms of MRTX1133 Resistance in PDAC Models
Poster Section 19 | Board 21 | #1888
April 20 | 09:00–12:00
• Development and Characterization of the Venetoclax-Resistant AML Model to Enable Preclinical Drug Discovery
Poster Section 18 | Board 23 | #1863
April 20 | 09:00–12:00
•Integrated ADC Platform: From Discovery to Functional Evaluation
Poster Section 12 | Board 7 | #1678
April 20 | 09:00–12:00
• Systematic Mechanistic Profiling of ADC-Resistant Cancer Cell Lines
Poster Section 12 | Board 1 | #2955
April 20 | 14:00–17:00
• An Integrated in Vitro Profiling Platform for the Simultaneous Assessment of Anti-Cancer Efficacy and Multi-Organ Toxicity
Poster Section 18 | Board 21 | #3153
April 20 | 14:00–17:00
Session Category: Immunology
• Combining PD-1 Blockade with DLL3-Targeted T Cell Engager Potentiates Antitumor Efficacy in Small Cell Lung Cancer
Poster Section 8 | Board 7 | #1553
April 20 | 09:00–12:00
Session Category: Chemistry
• Exploration of Novel E3 Ligase to Support Targeted Protein Degradation Drug Discovery
Poster Section 39 | Board 14 | #5164
April 21 | 09:00–12:00
• Development of a High-Throughput Assay Platform for the Screening of Selective Integrin Inhibitors in Cancer
Poster Section 39 | Board 12 | #6412
April 21 | 14:00–17:00
Session Category: Clinical Research
• From tLNP Selection to In Vitro/Vivo Efficiency Evaluation: In Vivo CAR-T Therapy
Poster Section 40 | Board 2 | #5184
April 21 | 09:00–12:00
Session Category: Tumor Biology
• Synchronously Implanted Cold Tumor Abrogates Anti-PD-1 Response of Hot Tumor in a Syngeneic Mouse Model
Poster Section 25 | Board 22 | #4804
April 21 | 09:00–12:00
Session Category: Experimental and Molecular Therapeutics
• Novel Non-CRBN Based Molecular Glue Identification and Corresponding E3 Ligase Target Deconvolution Through Multi-Omics Analysis
Poster Section 15 | Board 13 | #5786
April 21 | 14:00–17:00
• Therapeutic Potential of BTK-Targeted Degrader in B-Cell Malignancies Harboring Ibrutinib-Resistant Mutation
Poster Section 14 | Board 3 | #7114
April 22 | 09:00–12:00
To schedule a dedicated meeting with our team, please fill out the brief form on the right.
Resource Links
Cancer Pharmacology Services
Resource Type: Brochure
Research Chemistry Services
Resource Type: Brochure
WuXi AppTec Biology Services
Resource Type: Brochure
